Home / Leaderboard / Patient Capital Management, LLC
Patient Capital Management, LLC
Samantha McLemore · Asset Manager · Value
Patient Capital Management, LLC is a woman-owned independent investment firm based in Baltimore, Maryland, founded in 2020 by Samantha McLemore. The firm was established to continue and evolve the Opportunity Equity strategy, which McLemore co-managed for many years alongside legendary value investor Bill Miller at Miller Value Partners. In 2023, the firm officially acquired the Opportunity Equity business from Miller Value Partners. Patient Capital Management focuses on public equity markets, managing a range of investment products including mutual funds, private funds, and separately managed accounts. The team utilizes a research-intensive approach to identify long-term investment opportunities, often in contrarian or misunderstood areas of the market, while maintaining a lean, partnership-oriented structure.
Simulated Performance
| Metric | Value |
|---|---|
| Total return | +27.1% |
| YTD return | +15.3% |
| Sharpe ratio | 3.97 |
| Win rate | 80% |
| AUM | $2.5B |
| Inception | Oct 1, 2025 |
| Updated | Oct 2, 2026 |
Institution Status
| Field | Value |
|---|---|
| AUM | $2.5B |
| Turnover | Low (<15%) |
| Avg holding | 18 Months |
| Inception | Oct 1, 2025 |
| Website | https://patientcapitalmanagement.com/ |
Current Holdings
Updated on Oct 2, 2026.
| Ticker | Name | Portfolio % | Return |
|---|---|---|---|
| RPRX | Royalty Pharma Plc | 8.3% | +53.0% |
| C | Citigroup Inc | 7.5% | +30.0% |
| GOOGL | Alphabet Inc Class A | 7.2% | +40.4% |
| AMZN | Amazon.com Inc | 6.8% | +10.3% |
| UNH | UnitedHealth Group Incorporated | 6.6% | +8.6% |
| NVDA | NVIDIA Corporation | 6.4% | +23.6% |
| PGEN | Precigen Inc | 5.9% | +138.4% |
| META | Meta Platforms Inc. | 5.1% | +3.3% |
| ET | Energy Transfer LP | 4.9% | +19.2% |
| CHYM | Chime Financial, Inc. Class A Common Stock | 4.4% | +1.1% |
| CVS | CVS Health Corp | 4.3% | +12.3% |
| CROX | Crocs Inc | 4.0% | +18.0% |
| PPLI | People Incorporated | 3.9% | +2.6% |
| ILMN | Illumina Inc | 3.8% | +167.0% |
| SDRL | Seadrill Limited | 3.6% | +38.6% |
| COIN | Coinbase Global Inc | 3.6% | -1.9% |
| NCLH | Norwegian Cruise Line Holdings Ltd | 3.5% | -34.9% |
| QXO | QXO, Inc. | 3.5% | -34.7% |
| ADBE | Adobe Systems Incorporated | 3.4% | -1.9% |
| UAL | United Airlines Holdings Inc | 3.3% | +19.2% |
Recent activity
| Date | Action | Ticker | Weight |
|---|---|---|---|
| Sep 28, 2026 | BUY | UAL | 3.0% → 3.3% |
| Sep 28, 2026 | BUY | UNH | 7.1% → 6.6% |
| Sep 28, 2026 | BUY | PGEN | 3.2% → 5.9% |
| Sep 28, 2026 | BUY | QXO | 4.7% → 3.5% |
| Sep 28, 2026 | SELL | CROX | 3.8% → 4.0% |
Investment Style Analysis
Patient Capital Management, LLC is widely recognized for employing a Value strategy. As of Oct 2, 2026, the firm oversees approximately $2.5B in assets under management (AUM). The portfolio demonstrates a clear preference for the Internet Content & Information and Biotechnology sectors, reflecting a high-conviction approach to capital allocation.
Recent Market Moves
During the latest rebalancing period ending Sep 28, Patient Capital Management, LLC made a significant move by increasing exposure to UAL. This adjustment aligns with the fund's dynamic approach to risk management and capital deployment in current market conditions.
Investment Philosophy
The firm’s investment philosophy is rooted in long-term, contrarian value investing, emphasizing 'Time, not Timing.' They employ a flexible, benchmark-agnostic strategy that seeks to identify companies trading at a significant discount to their intrinsic value. The investment process is research-intensive and focused on human behavioral patterns, aiming to capitalize on market inefficiencies where fear or short-term thinking has mispriced a security's long-term potential. By maintaining a concentrated portfolio and a multi-year time horizon, the firm seeks to deliver superior risk-adjusted returns through fundamental analysis and disciplined capital allocation.
Disclaimer
The content provided on this page, including the simulated portfolio performance, holdings analysis, and AI-generated insights, is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All data is derived from historical SEC 13F filings and other public disclosures, which have a reporting lag. The "Simulated Performance" is a hypothetical reconstruction based on past disclosures and does not represent the actual returns of the institution. Past performance is not indicative of future results. Tritonix.ai is not affiliated with Patient Capital Management, LLC.
Similar Investment Style
Based on Value.
- Corstar Holdings, Inc. — Jeffrey J. Michael · 3M +17.7%
- Systematic Financial Management LP — Kenneth Burgess · 3M -7.3%
- Penn Capital Management Company, LLC — Richard A. Hocker · 3M -11.6%
- Reinhart Partners, LLC — James Reinhart · 3M -4.2%
Frequently asked questions
How is the simulated portfolio for Patient Capital Management, LLC constructed?
This simulation is powered by Tritonix AI using official SEC filings. We focus on the "Best Ideas" by filtering for only the Top 20 largest holdings and rebalancing them to 100%. The simulation tracks performance starting from Oct 1, 2025. Our AI monitors for updates every Monday to capture major shifts. This concentrated approach highlights the manager's true stock-picking skill and mirrors their actual investment returns.
What is Patient Capital Management, LLC's largest holding?
As of the latest filing, Patient Capital Management, LLC's top position is Royalty Pharma Plc (RPRX), representing 8.3% of the portfolio. This reflects a high-conviction bet by the institution.
What is Patient Capital Management, LLC's historical performance and risk profile?
Our simulation indicates a total return of +27.1% with a win rate of 80%. Notably, the portfolio maintains a Sharpe Ratio of 3.97, suggesting an exceptional level of risk-adjusted returns compared to the broader market.
What sectors does Patient Capital Management, LLC primarily invest in?
Patient Capital Management, LLC has a strong preference for the Internet Content & Information sector, which makes up 16.2% of their disclosed assets. The portfolio also has exposure to Biotechnology, indicating a specific thematic focus.
Is Patient Capital Management, LLC's portfolio concentrated or diversified?
Patient Capital Management, LLC runs a moderately concentrated portfolio with 20 disclosed positions. The top 3 holdings alone account for 23.1% of the total portfolio weight, suggesting a strategy that favors broader market exposure.
How has Patient Capital Management, LLC performed in 2026?
Our AI-simulated model portfolio for Patient Capital Management, LLC tracks a Year-to-Date (YTD) return of +15.3%. This metric helps investors gauge the institution's effectiveness in the current market environment.
Does Samantha McLemore manage Patient Capital Management, LLC directly?
Yes, Samantha McLemore serves as the key portfolio manager for Patient Capital Management, LLC, overseeing the investment strategy and final capital allocation decisions.